• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer.人脑中原位突变 huntingtin:全长单体普遍存在的证据。
J Biol Chem. 2012 Apr 13;287(16):13487-99. doi: 10.1074/jbc.M111.286609. Epub 2012 Feb 27.
2
Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain.人类淋巴母细胞系和人脑亨廷顿蛋白水解片段的比较。
J Neurochem. 2002 Jul;82(1):84-92. doi: 10.1046/j.1471-4159.2002.00940.x.
3
A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.一系列 N 端表位标记的 Hdh 基因敲入等位基因,表达正常和突变 huntingtin:它们在理解增加正常 Huntingtin 的 polyglutamine 延伸长度对 CAG140 小鼠模型发病机制的影响中的应用。
Mol Brain. 2012 Aug 14;5:28. doi: 10.1186/1756-6606-5-28.
4
Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.人脑中亨廷顿蛋白(htt)的组织特异性蛋白水解:亨廷顿病纹状体中N端和C端htt片段水平升高的证据。
J Neurosci. 2001 Mar 15;21(6):1830-7. doi: 10.1523/JNEUROSCI.21-06-01830.2001.
5
Multiple phenotypes in Huntington disease mouse neural stem cells.亨廷顿病小鼠神经干细胞的多种表型。
Mol Cell Neurosci. 2012 May;50(1):70-81. doi: 10.1016/j.mcn.2012.03.011. Epub 2012 Apr 6.
6
Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.突变型亨廷顿蛋白片段在体外和体内以多聚谷氨酰胺长度依赖性方式形成寡聚物。
J Biol Chem. 2010 May 7;285(19):14777-90. doi: 10.1074/jbc.M109.093708. Epub 2010 Mar 10.
7
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.野生型和突变型亨廷顿蛋白经半胱天冬酶3切割后的N端片段存在于正常及患亨廷顿舞蹈病的大脑中,与细胞膜相关联,并经历钙蛋白酶依赖性蛋白水解。
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12784-9. doi: 10.1073/pnas.221451398.
8
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC小鼠模型中,全长突变型亨廷顿蛋白对于纹状体神经元Ca2+信号改变和细胞凋亡是必需的。
Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16.
9
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.在亨廷顿舞蹈症中,突变型亨廷顿蛋白的半胱天冬酶切割先于神经退行性变。
J Neurosci. 2002 Sep 15;22(18):7862-72. doi: 10.1523/JNEUROSCI.22-18-07862.2002.
10
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.N端突变型亨廷顿蛋白与线粒体相关联并损害线粒体运输。
J Neurosci. 2008 Mar 12;28(11):2783-92. doi: 10.1523/JNEUROSCI.0106-08.2008.

引用本文的文献

1
Mutant huntingtin exon 1 protein detected in mouse brain with neoepitope antibody: effects of CAG repeat expansion, MutS Homolog 3 silencing and aggregation.用新表位抗体在小鼠大脑中检测到突变型亨廷顿蛋白外显子1:CAG重复序列扩增、MutS同源蛋白3沉默和聚集的影响
Brain Commun. 2025 Aug 29;7(5):fcaf314. doi: 10.1093/braincomms/fcaf314. eCollection 2025.
2
Detection of HTTex1p by western blot and immunostaining of HD human and mouse brain using neo-epitope antibody P90 highlights impact of CAG repeat expansion on its size, solubility, and response to MSH3 silencing.使用新表位抗体P90通过蛋白质免疫印迹法检测HTTex1p以及对亨廷顿舞蹈症患者和小鼠大脑进行免疫染色,突出了CAG重复序列扩增对其大小、溶解性以及对MSH3基因沉默反应的影响。
bioRxiv. 2025 Jan 1:2024.12.31.630891. doi: 10.1101/2024.12.31.630891.
3
A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington's disease.一种新型的 HDAC6 抑制剂,CKD-504,在亨廷顿病的临床前模型中治疗有效。
BMB Rep. 2023 Mar;56(2):178-183. doi: 10.5483/BMBRep.2022-0157.
4
PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington's disease.基于PAM改变单核苷酸多态性的等位基因特异性CRISPR-Cas9治疗亨廷顿舞蹈症的策略
Mol Ther Methods Clin Dev. 2022 Aug 14;26:547-561. doi: 10.1016/j.omtm.2022.08.005. eCollection 2022 Sep 8.
5
Allele-specific silencing of the gain-of-function mutation in Huntington's disease using CRISPR/Cas9.使用 CRISPR/Cas9 对亨廷顿病的功能获得性突变进行等位基因特异性沉默。
JCI Insight. 2022 Oct 10;7(19):e141042. doi: 10.1172/jci.insight.141042.
6
Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease.亨廷顿蛋白及其伴侣 Huntingtin 相关蛋白 40:在健康和疾病中的结构和功能考虑。
J Huntingtons Dis. 2022;11(3):227-242. doi: 10.3233/JHD-220543.
7
Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.美洲大陆和加勒比地区的脊髓小脑共济失调的奠基者效应。
Cerebellum. 2020 Jun;19(3):446-458. doi: 10.1007/s12311-020-01109-7.
8
A patient-derived cellular model for Huntington's disease reveals phenotypes at clinically relevant CAG lengths.用于亨廷顿病的患者来源细胞模型揭示了在临床相关 CAG 长度下的表型。
Mol Biol Cell. 2018 Nov 15;29(23):2809-2820. doi: 10.1091/mbc.E18-09-0590. Epub 2018 Sep 26.
9
Nuclear Localization of Huntingtin mRNA Is Specific to Cells of Neuronal Origin.亨廷顿 mRNA 的核定位特异性存在于神经元来源的细胞中。
Cell Rep. 2018 Sep 4;24(10):2553-2560.e5. doi: 10.1016/j.celrep.2018.07.106.
10
Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.抑制 MAPK11 或 HIPK3 可降低亨廷顿病模型中的突变 Huntingtin 水平。
Cell Res. 2017 Dec;27(12):1441-1465. doi: 10.1038/cr.2017.113. Epub 2017 Oct 13.

本文引用的文献

1
Huntington's disease: advocacy driving science.亨廷顿舞蹈病:倡导推动科学。
Annu Rev Med. 2012;63:1-22. doi: 10.1146/annurev-med-050710-134457.
2
Identifying polyglutamine protein species in situ that best predict neurodegeneration.在原位鉴定最能预测神经退行性变的多聚谷氨酰胺蛋白种类。
Nat Chem Biol. 2011 Oct 30;7(12):925-34. doi: 10.1038/nchembio.694.
3
Huntington's Disease.亨廷顿病。
Cold Spring Harb Perspect Biol. 2011 Jun 1;3(6):a007476. doi: 10.1101/cshperspect.a007476.
4
A compact beta model of huntingtin toxicity.亨廷顿毒性的紧凑型β模型。
J Biol Chem. 2011 Mar 11;286(10):8188-8196. doi: 10.1074/jbc.M110.192013. Epub 2011 Jan 5.
5
Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors.亨廷顿蛋白裂解产物 A 在神经元中形成,并被γ-分泌酶抑制剂减少。
Mol Neurodegener. 2010 Dec 14;5:58. doi: 10.1186/1750-1326-5-58.
6
Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.异常的 Rab11 依赖性神经元谷氨酸转运体 EAAC1 转运导致亨廷顿病中的氧化应激和细胞死亡。
J Neurosci. 2010 Mar 31;30(13):4552-61. doi: 10.1523/JNEUROSCI.5865-09.2010.
7
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.突变型亨廷顿蛋白的蛋白水解产生一个外显子 1 片段,该片段在亨廷顿病的神经元核中作为聚集蛋白积累。
J Biol Chem. 2010 Mar 19;285(12):8808-23. doi: 10.1074/jbc.M109.075028. Epub 2010 Jan 19.
8
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.丝氨酸 13 和 16 是全长人类突变 huntingtin 在 HD 小鼠中诱导疾病发病机制的关键决定因素。
Neuron. 2009 Dec 24;64(6):828-40. doi: 10.1016/j.neuron.2009.11.020.
9
Huntingtin facilitates polycomb repressive complex 2.亨廷顿蛋白促进多梳抑制复合物 2。
Hum Mol Genet. 2010 Feb 15;19(4):573-83. doi: 10.1093/hmg/ddp524. Epub 2009 Nov 23.
10
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.从亨廷顿病的 R6/2 及基因敲入小鼠模型的大脑中捕获到相同的寡聚体和纤维结构。
Hum Mol Genet. 2010 Jan 1;19(1):65-78. doi: 10.1093/hmg/ddp467.

人脑中原位突变 huntingtin:全长单体普遍存在的证据。

Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer.

机构信息

Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.

出版信息

J Biol Chem. 2012 Apr 13;287(16):13487-99. doi: 10.1074/jbc.M111.286609. Epub 2012 Feb 27.

DOI:10.1074/jbc.M111.286609
PMID:22375012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3339996/
Abstract

Huntington disease (HD) is caused by polyglutamine expansion in the N terminus of huntingtin (htt). Analysis of human postmortem brain lysates by SDS-PAGE and Western blot reveals htt as full-length and fragmented. Here we used Blue Native PAGE (BNP) and Western blots to study native htt in human postmortem brain. Antisera against htt detected a single band broadly migrating at 575-850 kDa in control brain and at 650-885 kDa in heterozygous and Venezuelan homozygous HD brains. Anti-polyglutamine antisera detected full-length mutant htt in HD brain. There was little htt cleavage even if lysates were pretreated with trypsin, indicating a property of native htt to resist protease cleavage. A soluble mutant htt fragment of about 180 kDa was detected with anti-htt antibody Ab1 (htt-(1-17)) and increased when lysates were treated with denaturants (SDS, 8 M urea, DTT, or trypsin) before BNP. Wild-type htt was more resistant to denaturants. Based on migration of in vitro translated htt fragments, the 180-kDa segment terminated ≈htt 670-880 amino acids. If second dimension SDS-PAGE followed BNP, the 180-kDa mutant htt was absent, and 43-50 kDa htt fragments appeared. Brain lysates from two HD mouse models expressed native full-length htt; a mutant fragment formed if lysates were pretreated with 8 M urea + DTT. Native full-length mutant htt in embryonic HD(140Q/140Q) mouse primary neurons was intact during cell death and when cell lysates were exposed to denaturants before BNP. Thus, native mutant htt occurs in brain and primary neurons as a soluble full-length monomer.

摘要

亨廷顿病(HD)是由亨廷顿(htt)N 端的多聚谷氨酰胺扩展引起的。SDS-PAGE 和 Western blot 分析人类死后脑组织裂解物显示 htt 全长和片段化。在这里,我们使用蓝色非变性 PAGE(BNP)和 Western blot 研究人类死后大脑中的天然 htt。针对 htt 的抗血清在对照大脑中检测到一条广泛迁移的单一条带,分子量为 575-850 kDa,在杂合子和委内瑞拉纯合子 HD 大脑中为 650-885 kDa。抗多聚谷氨酰胺抗血清在 HD 大脑中检测到全长突变 htt。即使裂解物先用胰蛋白酶预处理,htt 也很少被切割,表明天然 htt 具有抵抗蛋白酶切割的特性。用抗 htt 抗体 Ab1(htt-(1-17))检测到大约 180 kDa 的可溶性突变 htt 片段,当裂解物在用变性剂(SDS、8 M 尿素、DTT 或胰蛋白酶)预处理后再进行 BNP 时,该片段增加。野生型 htt 对变性剂的抵抗力更强。根据体外翻译的 htt 片段的迁移,180 kDa 片段终止于≈htt 670-880 个氨基酸。如果 BNP 后进行第二维 SDS-PAGE,则不存在 180 kDa 的突变 htt,而出现 43-50 kDa 的 htt 片段。来自两种 HD 小鼠模型的脑组织裂解物表达天然全长 htt;如果裂解物先用 8 M 尿素+DTT 预处理,则会形成突变片段。在细胞死亡期间以及在 BNP 之前将细胞裂解物暴露于变性剂时,胚胎 HD(140Q/140Q)小鼠原代神经元中的天然全长突变 htt 保持完整。因此,天然突变 htt 以可溶性全长单体的形式存在于大脑和原代神经元中。